These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 21150138

  • 1. Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of nonvertebral fractures among patients with COPD in the UK General Practice Research Database.
    Miller DP, Watkins SE, Sampson T, Davis KJ.
    Phys Sportsmed; 2010 Dec; 38(4):19-27. PubMed ID: 21150138
    [Abstract] [Full Text] [Related]

  • 2. Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database.
    Miller DP, Watkins SE, Sampson T, Davis KJ.
    Int J Chron Obstruct Pulmon Dis; 2011 Dec; 6():467-76. PubMed ID: 22003292
    [Abstract] [Full Text] [Related]

  • 3. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice.
    Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC.
    Eur Respir J; 2002 Oct; 20(4):819-25. PubMed ID: 12412670
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.
    Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, Shah T.
    Am J Respir Crit Care Med; 2002 Oct 15; 166(8):1084-91. PubMed ID: 12379552
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan 15; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 6. Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma.
    Delea TE, Hagiwara M, Stempel DA, Stanford RH.
    Allergy Asthma Proc; 2010 Jan 15; 31(3):211-8. PubMed ID: 20615321
    [Abstract] [Full Text] [Related]

  • 7. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
    Hagiwara M, Delea TE, Stanford RH, Stempel DA.
    Allergy Asthma Proc; 2010 Jan 15; 31(3):203-10. PubMed ID: 20534183
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
    Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T.
    Chest; 2003 Sep 15; 124(3):834-43. PubMed ID: 12970006
    [Abstract] [Full Text] [Related]

  • 9. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
    O'Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ, Knobil K.
    Chest; 2006 Sep 15; 130(3):647-56. PubMed ID: 16963658
    [Abstract] [Full Text] [Related]

  • 10. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.
    Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM.
    Curr Med Res Opin; 2009 Jan 15; 25(1):1-13. PubMed ID: 19210134
    [Abstract] [Full Text] [Related]

  • 11. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
    Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA, INSPIRE Investigators.
    Am J Respir Crit Care Med; 2008 Jan 01; 177(1):19-26. PubMed ID: 17916806
    [Abstract] [Full Text] [Related]

  • 12. The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease.
    Johannes CB, Schneider GA, Dube TJ, Alfredson TD, Davis KJ, Walker AM.
    Chest; 2005 Jan 01; 127(1):89-97. PubMed ID: 15653967
    [Abstract] [Full Text] [Related]

  • 13. Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone.
    Bailey W, Castro M, Matz J, White M, Dransfield M, Yancey S, Ortega H.
    Curr Med Res Opin; 2008 Jun 01; 24(6):1669-82. PubMed ID: 18462564
    [Abstract] [Full Text] [Related]

  • 14. Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.
    Kern DM, Davis J, Williams SA, Tunceli O, Wu B, Hollis S, Strange C, Trudo F.
    Respir Res; 2015 Apr 23; 16(1):52. PubMed ID: 25899176
    [Abstract] [Full Text] [Related]

  • 15. Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes.
    Anzueto A, Ferguson GT, Feldman G, Chinsky K, Seibert A, Emmett A, Knobil K, O'Dell D, Kalberg C, Crater G.
    COPD; 2009 Oct 23; 6(5):320-9. PubMed ID: 19863361
    [Abstract] [Full Text] [Related]

  • 16. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.
    Delea TE, Stanford RH, Hagiwara M, Stempel DA.
    Curr Med Res Opin; 2008 Dec 23; 24(12):3435-42. PubMed ID: 19032125
    [Abstract] [Full Text] [Related]

  • 17. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 18. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
    Hagiwara M, Delea TE, Stanford RH.
    Allergy Asthma Proc; 2014 Feb 22; 35(1):54-62. PubMed ID: 24433597
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
    Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS.
    Chest; 2007 Dec 22; 132(6):1756-63. PubMed ID: 17951625
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.
    Ferguson GT, Calverley PMA, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B.
    Chest; 2009 Dec 22; 136(6):1456-1465. PubMed ID: 19581353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.